TIMOTHY WEAVER: Open Payments
NPI 1285120048 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 77 payments from 21 companies in 2025. Trend: 2023 $1,288 · 2024 $1,231 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $361 |
| ViiV Healthcare Company | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| GlaxoSmithKline, LLC. | 4 | $60 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Exact Sciences Corporation | 3 | $49 |
| Novo Nordisk Inc | 2 | $47 |
| SHIELD THERAPEUTICS INC | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $30 |
Products named: VRAYLAR, UBRELVY, APRETUDE, CAPLYTA, Cologuard Collection Kit, Ozempic, ACCRUFER, Auvelity.
Industry payments across SC — which companies pay providers there.
